Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease

Scandinavian Journal of Immunology

Volumn 68, Issue 5, 2008, Pages 516-525

  Vitelli Avelar, D M ^a   Sathler Avelar, R ^a   Teixeira Carvalho, A ^a   Pinto Dias, J C ^a   Gontijo, E D ^b   Faria, A M ^b   Eloi Santos S M ^b   Martins Filho, O A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; INTERLEUKIN 10; PARASITE ANTIGEN;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CELL STIMULATION; CHAGAS DISEASE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DATA ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ADULT; AGED; ANIMALS; ANTIGENS, PROTOZOAN; B-LYMPHOCYTES; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NITROIMIDAZOLES; T-LYMPHOCYTES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 53549128946     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02167.x     Document Type: Article

References (28)

1. World Health Organization. New global effort to eliminate Chagas disease. Weekly Epidemiol Rec 2007 82 : 259 60.
2. Dias JC. Chagas disease: successes and challenges. Cad Saude Publica 2006 22 : 2020 1.
3. Pérez-Gutiérrez E, Agrelo RS, Figueroa R. Technical recommendation on Chagas' disease epidemiology and prevention, focusing its transmission as a disease transmitted by food. Rev Soc Bras Med Trop 2006 39 : 512 4.
4. + lymphocytes. Am J Trop Med Hyg 1993 48 : 637 44.
5. Dutra WO, Rocha MO, Teixeira MM. The clinical immunology of human Chagas disease. Trends Parasitol 2005 21 : 581 7.
6. High regulatory T lymphocytes. Scand J Immunol 2005 62 : 297 308.
7. Vitelli-Avelar DM, Sathler-Avelar R, Massara RL et al. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+ CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 2006 145 : 81 92.
8. Korbel DS, Finney OC, Riley EM. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004 34 : 1517 28.
9. Papazahariadou M, Athanasiadis GI, Papadopoulos E et al. Involvement of NK cells against tumors and parasites. Int J Biol Markers 2007 22 : 144 53.
10. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003 71 : 1185 93.
11. de Barros-Mazon S, Guariento ME, da Silva CA, Coffman RL, Abrahamsohn IA. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease. Clin Immunol 2004 111 : 137 45.
12. Bahia-Oliveira LM, Gomes JA, Rocha MO et al. IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res 1998 31 : 127 31.
13. Correa-Oliveira R, Gomes J, Lemos EL et al. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 1999 94 : 253 5.
14. Dutra WO, Gollob KJ, Pinto-Dias JC et al. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol 1997 45 : 74 80.
15. Souza PE, Rocha MO, Rocha-Vieira E et al. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 2004 72 : 5283 91.
16. Peruhype-Magalhães V, Martins-Filho OA, Prata A et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 2006 146 : 124 32.
17. Golgher D, Gazzinelli RT. Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 2004 37 : 399 409.
18. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004 25 : 677 86.
19. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003 3 : 23 35.
20. Noel W, Raes G, Hassanzadeh Ghass G, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol 2004 20 : 126 33.
21. Soares MB, Silva-Mota KN, Lima RS, Bellintani MC, Pontes-de-Carvalho L, Ribeiro-dos-Santos R. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am J Pathol 2001 159 : 703 9.
22. McKenzie AN, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993 90 : 3735 9.
23. Chakravarti A, Allaeys I, Poubelle PE. Neutrophil and immunity: is it innate or acquired? Med Sci 2007 23 : 862 7.
24. Eken C, Gasser O, Zenhaeusern G, Oehri I, Hess C, Schifferli JA. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J Immunol 2008 180 : 817 24.
25. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
26. Dittmer U, He H, Messer RJ. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004 20 : 293 303.
27. Sathler-Avelar R, Vitelli-Avelar DM, Massara RL. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect 2008 10 : 103 13.
28. Crema E, Monteiro IO, Gomes MG, Silva AA, Rodrigues Júnior V. Evaluation of cytokines (MIG, IFN-gamma, TNF-alpha, IL-4, IL-5, and IL-10) during the different evolutive phases of chagasic esophagopathy. Clin Immunol 2006 119 : 213 8.